GT Biopharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -3,114 | -1,433 | -775 | -3,775 |
EBIT | -3,864 | -3,763 | ||
Net Income | -3,114 | -1,433 | -776 | -3,775 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,677 | -3,014 | -2,202 | -2,468 |
Cash | 2,621 | 5,228 | 2,365 | 3,951 |
Basic Shares | 3,940 | 2,771 | 2,345 | 1,897 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -13,162 | 5,979 | -20,965 | -57,477 |
EBIT | -27,526 | -7,597 | -42,222 | -114,992 |
Net Income | -13,162 | -7,597 | -20,884 | -58,013 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,904 | -8,852 | -15,217 | -15,606 |
Cash | 3,951 | 1,079 | 5,672 | 8,968 |
Basic Shares | 1,897 | 1,348 | 31,868 | 28,155 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.83 |
2025-06-30 | -$0.55 |
2025-03-31 | -$0.33 |
2024-12-31 | -$1.66 |
